We're building a better ClinicalTrials.gov. Check it out and tell us what you think!

Key Record Dates

ClinicalTrials.gov Identifier: NCT03728361
Brief Title: Nivolumab and Temozolomide in Treating Patients With Recurrent or Refractory Small-Cell Lung Cancer or Advanced Neuroendocrine Cancer

First Submitted : October 29, 2018
First Submitted that Met QC Criteria : October 30, 2018
First Posted : November 2, 2018

Last Update Submitted that Met QC Criteria : April 27, 2022
Last Update Posted : April 29, 2022